Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
3.940
-0.130 (-3.19%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $93.74 million as of August 10, 2026. Its market cap has increased by 87.73% in one year.
Market Cap
93.74M
Enterprise Value
-9.72M
1-Year Change
87.73%
Ranking
Category
Stock Price
$3.94
ChartMarket Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $93.74M, a decrease of -56.30%. That is a compound annual growth rate of -44.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 93.74M | -40.61% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuCell | 99.51M |
| Pelthos Therapeutics | 98.57M |
| Cognition Therapeutics | 96.66M |
| Oncolytics Biotech | 95.78M |
| Aldeyra Therapeutics | 93.50M |
| Heron Therapeutics | 92.90M |
| PolyPid | 92.80M |
| Biomea Fusion | 91.10M |